Lumbar Epidural Steroid Injections for Spinal Stenosis Multicenter Randomized, Controlled Trial (LESS Trial)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The broad, long-term objective of this research protocol is to improve the quality of life for patients suffering from lumbar spinal stenosis. This objective will be met by examining the safety and clinical efficacy of epidural steroid injections for treatment of pain associated with lumbar spinal stenosis. This prospective, randomized, double-blind controlled trial (RCT) will test the hypothesis that the effectiveness of epidural steroid injections (ESI) plus local anesthetic (LA) is greater than epidural injections of LA alone in older adults with lumbar spinal stenosis.
| Condition | Intervention | Phase |
|---|---|---|
|
Spinal Stenosis Low Back Pain |
Procedure: Epidural steroid with local anesthetic injection Procedure: Epidural local anesthetic injection |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Crossover Assignment Masking: Double Blind (Subject, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Multicenter Randomized Controlled Trial of Epidural Steroid Injections for Spinal Stenosis in Persons 65 and Older |
- Roland Morris [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]The primary outcome measure will be back specific functional status, measured by the Roland Scale at 6 weeks. Our primary analysis will be a simple 2-group comparison of the mean Roland score as an evaluation of the short-term efficacy of epidural steroid injection.
- Pain Numeric Rating Scale [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 400 |
| Study Start Date: | April 2011 |
| Estimated Study Completion Date: | September 2013 |
| Estimated Primary Completion Date: | September 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Epidural Steroid injection
Epidural steroid injectate will be 2cc of .25 - 1% lidocaine followed by 1-3 cc of 40 mg/cc Kenalog (i.e. 40-120 mg Kenalog) or an equivalent steroid medication (depo-medrol 60-120 mg, betamethasone 6-12 mg or dexamethasone 8-10 mg) in an opaque syringe.
|
Procedure: Epidural steroid with local anesthetic injection
Epidural steroid injectate will be 2cc of 1% lidocaine followed by 1-3 cc of 40 mg/cc Kenalog (i.e. 40-120 mg Kenalog) or an equivalent steroid medication (depo-medrol 60-120 mg, betamethasone 6-12 mg or dexamethasone 8-10 mg) in an opaque syringe.
|
|
Active Comparator: Epidural local anesthetic injection
Epidural injectate will be 2cc of .25-1% lidocaine followed by 1-3cc of 1% lidocaine in an opaque syringe.
|
Procedure: Epidural local anesthetic injection
Epidural injectate will be 2cc of .25-1% lidocaine followed by 1-3cc of 1% lidocaine in an opaque syringe.
|
Detailed Description:
Lumbar spinal stenosis is one of the most common causes of low back pain in the elderly and can lead to significant disability. The symptoms of spinal stenosis range from low back pain to neurogenic claudication with lower extremity pain, weakness and/or sensory changes related to activities. As spinal stenosis can affect the central canal as well as the lateral recesses and intervertebral foramen variably, symptoms can involve single or multiple myotomes and dermatomes. Since the causes of spinal stenosis are most frequently degenerative changes, the symptoms of spinal stenosis often, but not always, worsen over time. Despite the prevalence of spinal stenosis, treatment of spinal stenosis remains somewhat controversial. Common treatments include conservative measures such as non-steroidal anti-inflammatories (NSAIDS), activity modification and physical therapy as well as more invasive treatments such as epidural steroid injections and surgery. Although surgery has been demonstrated to provide some benefit to many individuals with spinal stenosis, ESI are being used with increasing frequency as a less invasive, potentially more cost effective and safer treatment for spinal stenosis. However, there is a lack of data to demonstrate the effectiveness and safety of epidural steroid injections for spinal stenosis, particularly in the older adults.
Because of the compelling need for effective therapy for patients suffering from spinal stenosis and because epidural steroid injections are rapidly becoming standard of care for treating these patients - even in the absence of compelling clinical evidence - we are conducting a randomized, controlled trial in order to test the hypothesis that lumbar epidural steroid injections improve functional status and pain associated with spinal stenosis. The main objective of the study is to conduct a blinded, randomized controlled trial (RCT) in elderly patients with spinal stenosis to test if the effectiveness of epidural steroid injections (ESI) plus local anesthetic (LA) is greater than LA alone.
Eligibility| Ages Eligible for Study: | 50 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Pain in the low back, buttock, and/or lower extremity (pain NRS>5) with standing, walking and/or spinal extension (buttock/leg>back pain).
- Modified Roland-Morris score of at least 7.
- Mild-severe lumbar central canal spinal stenosis (Boden et al. criteria18) identified by MRI or CT scan.
- Lower extremity symptoms consistent with neurogenic claudication.
- Must be able to read English and complete the assessment instruments.
- Age 50 or older.
Exclusion Criteria:
- Cognitive impairment that renders the patient unable to give informed consent or provide accurate data.
Clinical co-morbidities that could interfere with the collection of data concerning pain and function.
Known dx of fibromyalgia, chronic widespread pain, amputees, parkinsons, head injury, dementia, stroke, other neurologic conditions Collect date about cervical spinal stenosis, painful peripheral neuropathy, EMGs
- Severe vascular, pulmonary or coronary artery disease that limits ambulation including recent myocardial infarction (within 6 months).
- Spinal instability requiring surgical fusion.
- Severe osteoporosis as defined by multiple compression fractures or a fracture at the same level as the stenosis.
- Metastatic cancer.
- Excessive alcohol consumption or evidence of non-prescribed or illegal drug use.
- Possible pregnancy or other reason that precludes the use of fluoroscopy.
- Concordant pain with internal rotation of the hip (or known hip joint pathology).
- Active local or systemic infection.
- Abnormal coagulation.
- Allergy to local anesthetic, steroid or contrast.
- Previous lumbar spine surgery.
- Epidural steroid injection within previous 6 months.
Contacts and Locations| Contact: Zoya Bauer, MD, PhD | 206 616-0313 | bauerz@uw.edu |
| Contact: Janna Friedly, MD | 206 616-0313 | friedlyj@uw.edu |
| United States, California | |
| Kaiser Permanente Northern California | Recruiting |
| Redwood City, California, United States, 94063 | |
| Contact: Michael Lin, MD, MPH 650-299-6009 Kyaw.X.Lin@nsmtp.kp.org | |
| Contact: Andrew Avins, MD, MPH 510-891-3557 andrew.avins@ucsf.edu | |
| Principal Investigator: Andrew Avins, MD, MPH | |
| Kaiser Permanente Northern California | Recruiting |
| Roseville, California, United States, 95661 | |
| Contact: Ted Diepenbrock 916-771-7742 M.Ted.Diepenbrock@kp.org | |
| Principal Investigator: Andrew Avins, MD, MPH | |
| United States, Colorado | |
| University of Colorado | Recruiting |
| Denver, Colorado, United States, 80045 | |
| Contact: Kelly Santo 303-724-4588 kelly.santo@ucdenver.edu | |
| Principal Investigator: Venu Akuthota, MD | |
| United States, Massachusetts | |
| Brigham and Women's Hospital | Recruiting |
| Boston, Massachusetts, United States, 02467 | |
| Contact: Brian Orrick, MBA 617-732-9816 brian.orrick@gmail.com | |
| Principal Investigator: Srdjan Nedeljkovic, MD | |
| United States, Michigan | |
| Henry Ford Hospital | Recruiting |
| Detroit, Michigan, United States, 48202 | |
| Contact: Lisa Pietrantoni, BS, HTL(ASCP), CCRC 313-916-3923 lpietra1@hfhs.org | |
| Principal Investigator: David Nerenz, PhD | |
| United States, Minnesota | |
| Mayo Clinic | Recruiting |
| Rochester, Minnesota, United States, 55905 | |
| Contact: Kathy Brown 507-538-2427 brown.kathy@mayo.edu | |
| Principal Investigator: Felix Diehn, MD | |
| United States, Oregon | |
| Oregon Health and Science University | Recruiting |
| Portland, Oregon, United States | |
| Contact: Paxton Gehling 503-494-5697 gehling@ohsu.edu | |
| Principal Investigator: David Sibell | |
| United States, Texas | |
| Dallas VA Medical Center | Recruiting |
| Dallas, Texas, United States, 75216 | |
| Contact: Desirae Ransom 214-857-1544 desirae.ransom@va.gov | |
| Principal Investigator: Thiru Annaswamy, MD | |
| United States, Virginia | |
| Virginia Spine Research Institute | Recruiting |
| Richmond, Virginia, United States, 23235 | |
| Contact: Kay Bovee 804-330-2611 crc@virginiaspineresearchinstitute.com | |
| Principal Investigator: Michael DePalma, MD | |
| United States, Washington | |
| Harborview Medical Center, University of Washington | Terminated |
| Seattle, Washington, United States, 98104 | |
| Principal Investigator: | Janna L Friedly, MD | University of Washington |
More Information
No publications provided by University of Washington
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Janna Friedly, Assistant Professor, University of Washington |
| ClinicalTrials.gov Identifier: | NCT01238536 History of Changes |
| Other Study ID Numbers: | 39023-A, R01HS19222-01 |
| Study First Received: | November 8, 2010 |
| Last Updated: | March 11, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Washington:
|
Epidural Steroid Injection Low Back Pain Spinal Stenosis Elderly |
Additional relevant MeSH terms:
|
Back Pain Constriction, Pathologic Low Back Pain Spinal Stenosis Pain Neurologic Manifestations Nervous System Diseases Signs and Symptoms Pathological Conditions, Anatomical Spinal Diseases Bone Diseases |
Musculoskeletal Diseases Anesthetics, Local Anesthetics Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions Sensory System Agents Peripheral Nervous System Agents Central Nervous System Agents Therapeutic Uses |
ClinicalTrials.gov processed this record on June 17, 2013